Anavex Life Sciences (AVXL) Amortizatization of Intangibles (2010 - 2016)
Anavex Life Sciences (AVXL) reported Amortizatization of Intangibles of $4655.0 for Q3 2016, down 99.67% on a YoY basis from $1.4 million in Q4 2015, and up 58087.5% sequentially from $8.0 in Q2 2016.
Anavex Life Sciences (AVXL) Amortizatization of Intangibles (2010 - 2016) Analysis & Trends
Anavex Life Sciences (AVXL) has 6 years of Amortizatization of Intangibles data on file, last reported at $4655.0 in Q3 2016.
- For the quarter ending Q3 2016, Amortizatization of Intangibles fell 99.67% year-over-year to $4655.0; the trailing twelve-month figure through Sep 2016 stood at $5830.0 (down 99.87% YoY), and the FY2016 full-year result was $5830.0, down 99.87% from the prior year.
- Amortizatization of Intangibles grew to $4655.0 in Q3 2016, from $8.0 in the prior quarter.
- In the past five years, Amortizatization of Intangibles ranged from a high of $2.6 million in Q2 2015 to a low of $8.0 in Q2 2016.
- A 4-year average of $499949.1 and a median of $7120.0 in 2014 frame the typical range for Amortizatization of Intangibles.
- Across the five-year window, Amortizatization of Intangibles soared 3269571.25% in 2015 and slumped 100.0% in 2016, its largest moves.
- Tracing AVXL's Amortizatization of Intangibles over 4 years: stood at $15293.0 in 2012, then plunged by 53.44% to $7120.0 in 2014, then sank by 84.62% to $1095.0 in 2015, then surged by 325.11% to $4655.0 in 2016.
- Business Quant data shows AVXL's Amortizatization of Intangibles at $4655.0 in Q3 2016, $8.0 in Q2 2016, and $72.0 in Q1 2016.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | - |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 3.22 Mn |
| 10 | Anavex Life Sciences | 223.91 Mn | 92.16 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2016 | 4,655.00 |
| Sep 30, 2016 | 4,655.00 |
| Jun 30, 2016 | 8.00 |
| Jun 30, 2016 | 8.00 |
| Mar 31, 2016 | 72.00 |
| Mar 31, 2016 | 72.00 |
| Dec 31, 2015 | 1,095.00 |
| Dec 31, 2015 | 1,095.00 |
| Sep 30, 2015 | 1.41 Mn |
| Sep 30, 2015 | 1.41 Mn |
| Jun 30, 2015 | 2.62 Mn |
| Jun 30, 2015 | 2.62 Mn |
| Mar 31, 2015 | 486,331.00 |
| Mar 31, 2015 | 486,331.00 |
| Dec 31, 2014 | 7,120.00 |
| Dec 31, 2014 | 7,120.00 |
| Sep 30, 2014 | 1.92 Mn |
| Sep 30, 2014 | 1.92 Mn |
| Jun 30, 2014 | 80.00 |
| Jun 30, 2014 | 80.00 |